Physicians Throughout U.S. Using Cardiovascular Systems, Inc.’ New Technology To Treat Coronary Artery Disease

Published: Dec 03, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that its new Diamondback 360® Coronary Orbital Atherectomy System (OAS) is being used by physicians across the country to treat coronary artery disease. This follows the company’s recent PMA approval from the U.S. Food and Drug Administration (FDA) to market the device as a treatment for severely calcified coronary arteries.

Help employers find you! Check out all the jobs and post your resume.

Back to news